We invite all authors and researchers to contribute their latest original research towards the Journal of Insulin Resistance.

The Journal of Insulin Resistance is a peer-reviewed, clinically oriented open access journal covering advances in disorders related to insulin resistance. Articles will focus on pathophysiology, prevention, management and advancing therapy for different patient populations with insulin resistance and related disorders, including obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, non-alcoholic steato-hepatitis, Alzheimer’s dementia, sexual dysfunction, amongst others. Read more…

The journal is DHET accredited because it is listed on the following approved indexing services:
• Directory of Open Access Journals (DOAJ) – DHET Approved Index from 2021

All articles published in the journal are included in:
• Directory of Open Access Journals
• GALE, CENGAGE Learning
• Google Scholar
• Norwegian Register for Scientific Journals, Series and Publishers, Level 1

We are working closely with relevant indexing services to ensure that articles published in the journal will be available in their databases when appropriate.

The journal has a double-blinded peer review process. Manuscripts are initially examined by editorial staff and are sent by the Editor-in-Chief to two expert independent reviewers, either directly or by a Section Editor. Read our full peer review process.

To contribute your latest research findings towards this publication, please visit insulinresistance.org. Please refer to the submissions procedure when submitting your original manuscripts. The author guidelines include information about the types of articles received for publication and preparing a manuscript for submission. Other relevant information about the journal’s policies and the reviewing process can be found under the about section.

Please visit our FAQs page for any other information you may require, and email submissions@insulinresistance.org for your support inquiry.